Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs Folic Acid in Diabetic Nephropathy
NCT07825961Completed
- Sponsor
- Tanta University
- Start
- Apr 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Trial of melatonin in diabetic nephropathy (DN) (3 arms), sponsored by Tanta University. Primary endpoint: Urine Albumin-to-Creatinine Ratio at 12 weeks. Started Apr 2025; status: completed.
02
Drugs
melatonin
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT07825961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07825961.